Efficacy and safety of acupoint embedding therapy compared with western medicine in the treatment of nonalcoholic fatty liver disease: a meta-analysis
by Baixing Xu; Haicheng Dong; Shifeng Zhu; Xiaoying Sun; Guodong Cong
International Journal of Computing Science and Mathematics (IJCSM), Vol. 19, No. 2, 2024

Abstract: The purpose of this study is to evaluate the efficacy and safety of acupoint embedding therapy in the treatment of nonalcoholic fatty liver disease (NAFLD). Articles published up to August 2021 were retrieved from PubMed, Embase, Cochrane Library, Web of Science, CNKI, VIP, WanFang, CBM, and the clinical trial registration database. This meta-analysis included 7 RCTs, involving 718 NAFLD patients. There is a statistically significant difference in the total efficacy rate between acupoint embedding therapy and western medicine (RR = 1.22, 95% CI: 1.11-1.34; P < 0.0001; I² = 0%). Acupoint embedding therapy has a huge association with improving TCM syndrome scores (MD = -3.46, 95% CI: -3.98 to -2.94; P < 0.00001; I² = 0%). Acupoint embedding therapy is more effective at treating NAFLD patients.

Online publication date: Fri, 08-Mar-2024

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Computing Science and Mathematics (IJCSM):
Login with your Inderscience username and password:

Username:        Password:          Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com